{"id":"nonselective-beta-blocker","safety":{"commonSideEffects":[{"rate":"null","effect":"Bradycardia"},{"rate":"null","effect":"Hypotension"},{"rate":"null","effect":"Dyspnea"}]},"_chembl":{"chemblId":"CHEMBL1402326","moleculeType":"Small molecule","molecularWeight":"540.13"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Nonselective beta blockers, such as the one in question, work by binding to beta-adrenergic receptors in the heart and blood vessels, thereby reducing the effects of the sympathetic nervous system. This results in decreased heart rate, reduced cardiac output, and vasodilation, ultimately leading to decreased blood pressure and reduced myocardial oxygen demand.","oneSentence":"Blocks the action of beta-adrenergic receptors, leading to decreased heart rate and blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:50:28.072Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Angina pectoris"}]},"trialDetails":[{"nctId":"NCT05572957","phase":"NA","title":"LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2022-10-14","conditions":"Non-ischemic Cardiomyopathy, Heart Failure, Left Bundle-Branch Block","enrollment":50},{"nctId":"NCT06594744","phase":"PHASE4","title":"Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCC","status":"RECRUITING","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2024-10-01","conditions":"Hepatocellular Carcinoma (HCC), Esophageal Varices","enrollment":120},{"nctId":"NCT06594783","phase":"PHASE4","title":"Carvedilol Plus EVL or Not for the Primary Prevention of Esophageal Variceal Bleeding in Carvedilol Non-responders","status":"RECRUITING","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2025-01-06","conditions":"Cirrhosis, Esophageal Varices","enrollment":80},{"nctId":"NCT02649335","phase":"PHASE3","title":"To Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With Ascites","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2015-07-01","conditions":"Ascites","enrollment":190},{"nctId":"NCT05651789","phase":"NA","title":"Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding","status":"UNKNOWN","sponsor":"West China Hospital","startDate":"2023-01","conditions":"Portal Hypertension, Varice Bleed, Cirrhosis, Liver","enrollment":160},{"nctId":"NCT02809820","phase":"PHASE4","title":"Effects of Beta-blockade on Platelet Aggregation in Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Federico II University","startDate":"2016-05","conditions":"Acute Coronary Syndrome","enrollment":100},{"nctId":"NCT05106179","phase":"PHASE4","title":"The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma","status":"UNKNOWN","sponsor":"Center for Vascular Pathology, Moscow","startDate":"2021-12","conditions":"Spinal Tumor, Spinal Hemangioma, Beta Blocker Toxicity","enrollment":1000},{"nctId":"NCT04704947","phase":"PHASE3","title":"Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis","status":"RECRUITING","sponsor":"Sherief Abd-Elsalam","startDate":"2017-10-01","conditions":"Beta Blocker Toxicity","enrollment":50},{"nctId":"NCT04207398","phase":"NA","title":"TIPS vs. NSBB Plus Endotherapy for the Prevention of Variceal Rebleeding in NSBB Non-responders of Primary Prophylaxis","status":"UNKNOWN","sponsor":"Air Force Military Medical University, China","startDate":"2020-06-01","conditions":"Variceal Hemorrhage, TIPS, NSBB","enrollment":114},{"nctId":"NCT04074473","phase":"PHASE4","title":"Impact of Nonselective Beta-blocker on Acute Kidney Injury in Cirrhotic Patients With Esophageal Varices","status":"UNKNOWN","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2015-04-13","conditions":"Acute Kidney Injury, Cirrhosis, Esophageal Varices","enrollment":170},{"nctId":"NCT02583698","phase":"NA","title":"Efficacy of Nonselective Beta Blocker vs Placebo in Patients With Acute-on-chronic Liver Failure With Small/ no Esophageal Varices","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2015-10-01","conditions":"Acute on Chronic Liver Failure","enrollment":136},{"nctId":"NCT03687216","phase":"NA","title":"HVPG-Guided Therapy Versus EVL Plus NSBB in Second Prophylaxis of Esophageal Variceal Bleeding","status":"UNKNOWN","sponsor":"West China Hospital","startDate":"2019-09","conditions":"Esophageal Varices in Cirrhosis of the Liver","enrollment":160},{"nctId":"NCT00006398","phase":"PHASE3","title":"Prevention of Esophageal Varices by Beta-Adrenergic Blockers","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"1993-08","conditions":"Esophageal and Gastric Varices, Liver Cirrhosis, Portal Hypertension","enrollment":213},{"nctId":"NCT01897051","phase":"PHASE2, PHASE3","title":"Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2013-07","conditions":"Liver Cirrhosis, Portal Hypertension","enrollment":140}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Inderal"],"phase":"phase_3","status":"active","brandName":"nonselective beta blocker","genericName":"nonselective beta blocker","companyName":"Sherief Abd-Elsalam","companyId":"sherief-abd-elsalam","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Blocks the action of beta-adrenergic receptors, leading to decreased heart rate and blood pressure. Used for Hypertension, Angina pectoris.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}